These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22290956)

  • 1. Dynamic interaction between fluconazole and amphotericin B against Cryptococcus gattii.
    Santos JR; Gouveia LF; Taylor EL; Resende-Stoianoff MA; Pianetti GA; César IC; Santos DA
    Antimicrob Agents Chemother; 2012 May; 56(5):2553-8. PubMed ID: 22290956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
    Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K
    J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrogen concentration affects amphotericin B and fluconazole tolerance of pathogenic cryptococci.
    Bosch C; Toplis B; Vreulink JM; Volschenk H; Botha A
    FEMS Yeast Res; 2020 Mar; 20(2):. PubMed ID: 32073632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.
    Cordeiro RA; Evangelista AJJ; Serpa R; Marques FJF; Melo CVS; Oliveira JS; Franco JDS; Alencar LP; Bandeira TJPG; Brilhante RSN; Sidrim JJC; Rocha MFG
    Microbiology (Reading); 2016 Feb; 162(2):309-317. PubMed ID: 26645478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of oxidative and nitrosative bursts caused by azoles and amphotericin B against the fungal pathogen Cryptococcus gattii.
    Ferreira GF; Baltazar Lde M; Santos JR; Monteiro AS; Fraga LA; Resende-Stoianoff MA; Santos DA
    J Antimicrob Chemother; 2013 Aug; 68(8):1801-11. PubMed ID: 23612570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Darunavir inhibits
    Brilhante RSN; Silva JAT; Araújo GDS; Pereira VS; Gotay WJP; Oliveira JS; Guedes GMM; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    J Med Microbiol; 2020 Jun; 69(6):830-837. PubMed ID: 32459616
    [No Abstract]   [Full Text] [Related]  

  • 7. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
    Spadari CC; Vila T; Rozental S; Ishida K
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
    [No Abstract]   [Full Text] [Related]  

  • 8. Cryptococcus neoformans/Cryptococcus gattii species complex melanized by epinephrine: Increased yeast survival after amphotericin B exposure.
    Brilhante RSN; Rocha MGD; Oliveira JS; Pereira-Neto WA; Guedes GMM; Cordeiro RA; Sidrim JJC; Rocha MFG; Castelo-Branco DSCM
    Microb Pathog; 2020 Jun; 143():104123. PubMed ID: 32169493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro.
    Pereira de Sá N; Lino CI; Fonseca NC; Borelli BM; Ramos JP; Souza-Fagundes EM; Rosa CA; Santos DA; Barbosa de Oliveira R; Johann S
    Eur J Med Chem; 2015 Sep; 102():233-42. PubMed ID: 26276437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
    Franzot SP; Casadevall A
    Antimicrob Agents Chemother; 1997 Feb; 41(2):331-6. PubMed ID: 9021188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans.
    Klepser ME; Wolfe EJ; Pfaller MA
    J Antimicrob Chemother; 1998 Mar; 41(3):397-401. PubMed ID: 9578168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activity of eicosanoic acids isolated from the endophytic fungus Mycosphaerella sp. against Cryptococcus neoformans and C. gattii.
    Pereira CB; Pereira de Sá N; Borelli BM; Rosa CA; Barbeira PJS; Cota BB; Johann S
    Microb Pathog; 2016 Nov; 100():205-212. PubMed ID: 27693577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics/pharmacodynamic correlations of fluconazole in murine model of cryptococcosis.
    Santos JR; César IC; Costa MC; Ribeiro NQ; Holanda RA; Ramos LH; Freitas GJ; Paixão TA; Pianetti GA; Santos DA
    Eur J Pharm Sci; 2016 Sep; 92():235-43. PubMed ID: 27235581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii.
    Vu K; Gelli A
    Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis.
    Santos JRA; Ribeiro NQ; Bastos RW; Holanda RA; Silva LC; Queiroz ER; Santos DA
    Sci Rep; 2017 Jul; 7(1):4661. PubMed ID: 28680034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii.
    Mendes FE; Oliveira LV; Faria ES; Alvarenga DG; Pinto MR; Taborda CP; Soares BM; Cisalpino PS; Santos DA
    Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1525-32. PubMed ID: 20803047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarials and amphotericin B interact synergistically and are new options to treat cryptococcosis.
    Freitas GJC; Ribeiro NQ; Gouveia-Eufrasio L; Emidio ECP; Guimarães GM; César IC; Paixão TA; Oliveira JBS; Caza M; Kronstad JW; Santos DA
    Int J Antimicrob Agents; 2023 Jul; 62(1):106807. PubMed ID: 37030471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains.
    Silva DC; Martins MA; Szeszs MW; Bonfietti LX; Matos D; Melhem MS
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):332-9. PubMed ID: 22341512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.
    Nooney L; Matthews RC; Burnie JP
    Diagn Microbiol Infect Dis; 2005 Jan; 51(1):19-29. PubMed ID: 15629225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.